Loss of heterozygosity at chromosome segment Xq25-26.1 in Advanced human ovarian carcinomas

Genes Chromosomes and Cancer

Volumn 20, Issue 3, 1997, Pages 234-242

  Choi, Chan ^a   Cho, Sunghee ^a   Horikawa, Izumi ^a   Berchuck, Andrew ^b   Wang, Nancy ^c   Cedrone, Edward ^c   Jhung, Sang Woo ^d   Lee, Jung Bin ^e   Kerr, Judith ^f   Chenevix Trench, Georgia ^f   Kim, Seongyeon ^g   Barrett, J Carl ^a   Koi, Minoru ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^d Chonnam National University Medical School   (South Korea)

^e Seoul National University College of Medicine   (South Korea)

^f QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^g NORTH CAROLINA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ADVANCED CANCER; ARTICLE; CANCER GRADING; CANCER STAGING; CHROMOSOME 17; CHROMOSOME XQ; CONTROLLED STUDY; FEMALE; GENE LOCUS; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; OVARY CARCINOMA; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

CARCINOMA; CHROMOSOME MAPPING; DNA, NEOPLASM; FEMALE; GENES, P53; GENES, TUMOR SUPPRESSOR; HUMANS; LOSS OF HETEROZYGOSITY; MICROSATELLITE REPEATS; NEOPLASM STAGING; OVARIAN NEOPLASMS; POLYMERASE CHAIN REACTION; X CHROMOSOME;

EID: 0030815870     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2264(199711)20:3<234::AID-GCC3>3.0.CO;2-3     Document Type: Article

References (48)

1. Agresti A (1990) Models for binary response variables. In: Categorial Data Analysis. New York: John Wiley & Sons, pp 79-129.
2. Allen RC, Zoghbi HY, Moseley AB, Rosenblatt HM, Belmont JW (1992) Methylation of HpaII and HhaI sites near the polymorphic CAG repeat in the human androgen-receptor gene correlates with X chromosome inactivation. Am J Hum Genet 51:1229-1239.
3. Borrensen AL (1992) Oncogenesis in ovarian cancer. Acta Obstet Gynecol Scand 155:25-30.
4. Bouloux PMG, Hardelin JR Munroe P, Kirk JMW, Legouis R, Levilliers J, Hazan J, Weissenbach J, Petit C (1991) A dinucleotide repeat polymorphism at the Kallmann locus (Xp22.3). Nucl Acids Res 19:5453.
5. Carvalho MRS, Medindl A, Strom TM, Muller B, Wittwer B, Ross M, Meitinger T (1994) X-chromosomal retinitis pigmentosa: Genetic mapping and cloning approaches. Cytogenet Cell Genet 67:343.
6. Chenevix-Trench, Leary J, Kerr J, Michel J, Kefford R, Hurst T, Parsons, PG, Friedlander M, Khoo SK (1992) Frequent loss of heterozygosity on chromosome 18 in ovarian adenocarcinoma which does not always include the DCC locus. Oncogcne 7:1059-1065
7. Chenevix-Trench G, Kerr J, Friedlander M, Hurst T, Sanderson B, Coglan M, Ward B, Leary J, Khoo S-K (1994) Homozygous deletions on the short arm of chromosome 9 in ovarian adenocarcinoma cell lines and loss of heterozygosity in sporadic tumors. Am J Hum Genet 55:143-149.
8. Chenevix-Trench G, Kerr J, Hurst T, Shih Y-C, Purdie D, Bergman L. Friedlander M, Sanderson B. Zournazi A, Coombs T, Leary JA, Crawford E, Shelling AN, Cooke I, Ganesan TS, Searle J, Choi C, Barrett JC, Khoo S-K, Ward B (1997) Analysis of loss of heterozygosity and K-ras mutations and in ovarian neoplasms: Clinicopathological correlations. Genes Chromosomes Cancer 18:75-83.
9. Cheng PC, Gosewehr JA, Kim TM, Velicescu M, Wan M, Zheng J, Felix JC, Cofer KF, Luo P, Biela BH, Godorov G, Dubeau L (1996) Potential role of the inactivated X chromosome in ovarian epithelial tumor development. J Natl Cancer Inst 88:510-518.
10. Clemens PR, Fenwick RG, Chamberlain JS, Gibbs RA, de Andrade M, Chakraborty R (1991) Carrier detection and prenatal diagnosis in Duchenne and Becker muscular dystrophy families, using dinucleotidc repeat polymorphism. Am J Hum Genet 49:951-960.
11. Cliby W, Ritland S, Hartmann L, Dodson M, Halling KC, Keeney G, Podratz, KC, Jenkins RB (1993) Human epithelial ovarian cancer allelotype. Cancer Res 53:2393-2398.
12. Coleman MP, Murray JC, Willard HF, Nolan KF, Reid KBM, Blake DJ, Lindsay S, Bhattacharya SS, Wright A, Davies KE (1991) Genetic and physical mapping around the properdin P gene. Genomics 11:991-996.
13. Edwards A, Hammond HA, Jin L, Caskey T, Chakraborty R (1992) Genetic variation at five trimeric and tetrameric tandem repeat loci in four human population groups. Genomics 12:241-253.
14. Futreal PA, Barrett JC, Wiseman RW (1991) An Alu polymorphism intragenic to the TP53 gene. Nucl Acids Res 19:6977.
15. Gallion HH, Powell DE, Smith LW, Morrow JK, Martin AW, van Nagell JR, Donaldson ES (1990) Chromosome abnormalities in human epithelial ovarian malignancies. Gynecol Oncol 38:473-477.
16. Gedeon AK, Holman K, Richards RI, Mulley JC (1992) Characterization of new PCR based markers for mapping and diagnosis: AC repeat markers at the DXS237 (GMGX9) and DXS102 (cX 38.1). Am J Med Genet 43:255-260.
17. Gyapay G, Morissette J, Vignal A, Dib C, Fizames C, Millasseau P, Marc S, Bernardi G, Lathrop M, Weissenbach J (1994) The 1993-94 Généthon human genetic linkage map. Nat Genet 7:246-339.
18. Hinds HL, Hendriks RW, Craig IW, Chen ZY (1992) Characterization of a highly polymorphic region near the first exon of the human MAOA gene containing a GT dinucleotide and a novel VNTR motif. Genomics 13:896-897.
19. Ignar-Trowbridge D, Risinger JI, Dent GA, Kohler M, Becrchuck A, McLachlan JA, Boyd J (1992) Mutation of the Ki-ras oncogene in endometrial carcinoma. Am J Obstet Gynecol 176:227-232.
20. Iwabuchi H, Sakamoto M, Sakunaga H, Ma Y-Y, Carcangiv ML, Pinkel D, Yang-Feng TL, Gray JW (1995) Genetic analysis of benign, low-grade, and high grade ovarian tumors. Cancer Res 55:6172-6180.
21. Jenkins RB, Bartelt D, Stalboerger P, Persons D, Dahl RJ, Podratz K, Keeney G, Hartmann L (1993) Cytogenetic studies of epithelial ovarian carcinoma. Cancer Genet Cytogenet 71:76-86.
22. Klein CB, Conway K, Wang XW, Bhamra RK, Lin X, Cohen MD, Annab L, Barrett JC, Costa M (1991) Senescence of nickel-transformed cells by an X chromosome: Possible epigenetic control. Science 251:796-799.
23. Knudson AG (1971) Mutations and cancer: Statistical study of retinoblastoma. Proc Natl Acad Sci USA 68:820-823.
24. Lee JH, Kavanagh JJ, Wildrick DM, Wharton JT, Blick M (1990) Frequent loss of heterozygosity on chromosomes 6q, 11, and 17 in human ovarian carcinomas. Cancer Res 50:2724-2728.
25. Mazars R, Pujol P, Maudelonde T, Jeanteur P, Theillet C (1991) p53 mutations in ovarian cancer, a late event? Oncogene 6:1685-1690.
26. Miller AP, Gustashaw K, Wolff DJ, Rider SH, Monaco AP, Eble B, Schlessinger D, Gorski JL, van Ommen GJ, Weissenbach J, Willard HF (1995) Three genes that escape X chromosome inactivation are clustered within 6 Mb YAC contig and STS map in Xp11.21-p11.22. Hum Mol Genet 4:731-739.
27. Milner B, Allan L, Eccles D, Kitchener H, Leonard R, Kelly K, Parkin D, Haites N (1993) p55 mutation is a common genetic event in ovarian carcinoma. Cancer Res 53:2128-2132.
28. Mitra AB, Murty VVVS, Li RG, Pratap M, Luthra UK, Chaganti RSK (1994) Allelotype analysis of cervical carcinoma. Cancer Res 54:4481-1487
29. Moore BJ, Kwan S.P, Bech-Hansen NT (1992) A polymorphic dinucleotide repeat at the DXS7 locus. Nucl Acids Res 20:929.
30. Osborne RJ, Leech Y (1994) Polymerase chain reaction allelotyping of human ovarian cancer. Br J Cancer 69:429-438.
31. Oudet C, Weber C, Kaplan J, Segues B, Croquette MF, Roman, EO, Hanauer A (1993) Characterization of a highly polymorphic microsatellite at the DXS207 locus: Confirmation of very close linkage to the retinoschisis disease gene. J Med Genet 30:500-303.
32. Pejovic T, Heim S, Mandahl N, Elmfors H, Floderus L-M, Furgyik S, Helm G, Willén H, Mitelman F (1989) Consistent occurrence of a 19p+ marker chromosome and loss of 11p material in ovarian seropapillary cystadenocarcinomas. Genes Chromosomes Cancer 1:167-171.
33. Pejovic T, Heim S, Mandahl N, Elmfors B, Furgyik S, Flodérus L-M, Helm G, Willén H, Mitelman F (1991) Bilateral ovarian carcinoma: Cytogenetic evidence of unicentral origin. Int J Cancer 47:358-361.
34. Pejovic T, Heim S, Mandahl N, Baldetorp B, Elmfors B, Flodérus U-M, Furgyik S, Helm G, Himmelmann A, Willén H, Mitelman F (1992) Chromosome aberrations in 35 primary ovarian carcinomas. Genes Chromsomes Cancer 4:58-68.
35. Sato T, Saito H, Morita R, Koi S, Lee JH, Nakamura Y (1991) Allelotype of human ovarian cancer. Cancer Res 51:5118-5122.
36. Schwab M, Amler LC (1990) Amplification of cellular oncogenes: A predictor of clinical outcome in human cancer. Genes Chromosomes Cancer 1:181-193.
37. Slamon DJ, Godolphin W, Jones LA, Holt JA, Wong SG, Keith DE, Levin WJ, Stuart SG, Udove J, Ullrich A, Press MF (1989) Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science 244:707-712.
38. Teneriello MG, Ebina M, Linnoila RI, Henry M, Nash JD, Park RC, Birrer MJ (1993) p53 and Ki-ras gene mutations in epithelial ovarian neoplasms. Cancer Res 53:3103-3108.
39. Thompson FH, Emerson J, Albert D, Liu Y, Guan XY, Burgess A, Fox S, Taetle R, Weinstein R, Makar R, Powel D, Trent T (1994) Clonal chromosome abnormalities in 54 cases of ovarian carcinoma. Cancer Genet Cytogenet 73:33-45.
40. Thrash-Bingham CA, Salazar H, Greenberg RE, Tartof KD (1996) Loss of heterozygosity studies indicate that chromosome arm 1p harbors a tumor suppressor gene for renal oncocytomas. Genes Chromosomes Cancer 16:64-67.
41. Vandamme B, Lissens W, Amfo K, Sutter PD, Bourgain C, Vamos E, Gréve JD (1992) Deletion of chromosome 11p13-11p15.5 sequences in invasive human ovarian cancer is a subclonal progression factor. Cancer Res 52:6646-66542.
42. Wang XW, Lin X, Klein CB, Bhamra RK, Lee Y-W, Costa MA (1992) A conserved region in human and Chinese hamster X chromosomes can induce cellular senescence of nickel-transformed Chinese hamster cell lines. Carcinogenesis 13:555-561.
43. Weber JL, Kwitek AF, May PE, Polymeropoulos MH, Ledbetter S (1990) Dinucleotide repeat polymorphisms at the DXS453 and DXS458 loci. Nucl Acids Res 18:4037.
44. Weissenbach J, Gyapay G, Dib C, Vignal A, Morissette J, Millasseau P, Vaysseix G, Lathrop M (1992) A second-generation linkage map of the human genome. Nature 359:794-801.
45. Willard HF, Cremers JL, Mandel JL, Monaco AP, Nelson DL, Schlessinger D (1994) Report of the fifth international workshop on human X chromosome mapping 1994. Cytogenet Cell Genet 67:296-327.
46. Yang-Feng TL, Li S, Han H, Schwartz, PE (1992) Frequent loss of heterozygosity on chromosomes Xp and 13q in human ovarian cancer. Int J Cancer 52:575-580.
47. Yang-Feng TL, Han H, Chen K-C, Li S, Claus FB, Carcangiu ML, Chambers SK, Chambers JT, Schwartz PE (1993) Allelic loss in ovarian cancer. Int J Cancer 54:546-551.
48. Zheng J, Robinson WR, Ehlen T, Yu MC, Dubeau L (1991) Distinction of low grade from high grade human ovarian carcinomas on the basis of losses of heterozygosity on chromosomes 3, 6, and 11 and HER-2/neu gene amplification. Cancer Res 51:4045-4051.